Form 8-K - Current report:
SEC Accession No. 0001683168-24-008607
Filing Date
2024-12-10
Accepted
2024-12-10 16:26:24
Documents
14
Period of Report
2024-12-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sunshine_8k.htm   iXBRL 8-K 32748
  Complete submission text file 0001683168-24-008607.txt   249511

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sbfm-20241210.xsd EX-101.SCH 3553
3 XBRL DEFINITION FILE sbfm-20241210_def.xml EX-101.DEF 26585
4 XBRL LABEL FILE sbfm-20241210_lab.xml EX-101.LAB 36550
5 XBRL PRESENTATION FILE sbfm-20241210_pre.xml EX-101.PRE 25209
16 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5522
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 241538830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)